logo

FLGT

Fulgent Genetics·NASDAQ
--
--(--)
--
--(--)
0.69 / 10
Underperform

Fundamental score: 0.7/10 indicating challenging quality. Bullish factors include Total operating revenue (YoY growth rate %) and Operating revenue (YoY growth rate %), though challenges appear in Long-term debt to working capital ratio (%) and Inventory turnover days.. Overall assessment: challenging.

Fundamental(0.69)SentimentTechnical

Analysis Checks(5/10)

Total operating revenue (YoY growth rate %)
Value15.48
Score2/3
Weight7.24%
1M Return-1.43%
Quick ratio
Value2.20
Score2/3
Weight-2.72%
1M Return0.56%
Total profit (YoY growth rate %)
Value7.20
Score0/3
Weight25.94%
1M Return-5.82%
Net cash flow from operating activities (YoY growth rate %)
Value-493.61
Score0/3
Weight26.01%
1M Return-5.07%
Fixed assets turnover ratio
Value2.20
Score3/3
Weight-23.76%
1M Return4.11%
Long-term debt to working capital ratio (%)
Value0.05
Score1/3
Weight11.88%
1M Return-2.30%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight8.62%
1M Return-1.71%
Operating revenue (YoY growth rate %)
Value15.48
Score2/3
Weight7.24%
1M Return-1.43%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value-0.75
Score0/3
Weight25.48%
1M Return-5.92%
Inventory turnover days
Value232.28
Score1/3
Weight14.07%
1M Return-3.18%
Is FLGT fundamentally strong?
  • FLGT scores 0.69/10 on fundamentals and holds a Premium valuation at present. Backed by its -3.30% ROE, -14.00% net margin, -16.86 P/E ratio, 0.65 P/B ratio, and 74.64% earnings growth, these metrics solidify its Underperform investment rating.